BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 46 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 46 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
AlphaGraphs

Key metrics from Kimberly-Clark’s (KMB) Q4 2024 earnings results

Kimberly-Clark Corporation (NYSE: KMB) reported its fourth quarter 2024 earnings results today. Sales were $4.9 billion, down 0.8% from the same period last year. Organic sales were up 2.3%. Net income attributable to Kimberly-Clark Corporation decreased 12.2% to $447 million while earnings per share dropped 10.7% to $1.34. Adjusted EPS decreased 0.7% to $1.50. For fiscal […]

$KMB January 28, 2025 1 min read

Kimberly-Clark Corporation (NYSE: KMB) reported its fourth quarter 2024 earnings results today.

Sales were $4.9 billion, down 0.8% from the same period last year. Organic sales were up 2.3%.

Net income attributable to Kimberly-Clark Corporation decreased 12.2% to $447 million while earnings per share dropped 10.7% to $1.34. Adjusted EPS decreased 0.7% to $1.50.

For fiscal year 2025, KMB expects adjusted EPS to grow at a mid-to-high single-digit rate on a constant-currency basis.

Prior performance

ADVERTISEMENT